A 70-year-old woman with chronic kidney disease (eGFR 38 mL/min/1.73 m²) and persistent albuminuria attends for blood pressure review. Her average clinic blood pressure is 146/88 mmHg despite maximised ACE inhibitor therapy. According to Australian CKD guidance, what is the most appropriate next step in pharmacological blood pressure management?